Abstract
Evidence about benefits and risks of medicines can guide the communication about risks and safe use of medicinal products—but not all the way. Ethical questions arise when science cannot produce conclusive answers to important questions or when there is a tension between scientific knowledge and other values, beliefs or perceptions. Examples are questions around new, inconclusive evidence about potential adverse effects of marketed medicines or regarding unintended effects of risk communication, such as shame, changes in therapy adherence or stigmatisation experienced by individuals using a certain medicine. Ensuring adequate and timely communication about risks and safe use of medicines therefore depends partly on ethical considerations, such as the duty of beneficence to patients and communities, the patient right to autonomy and collective responsibility. Health communication practices need to be based on a fair balance of relevant ethical norms and values. In this chapter, an ethical perspective on medicinal product risk communication will be introduced and four areas of ethical tension and the contexts of uncertainty and trust are discussed, which should be taken into account when planning or evaluating communication events.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler D, Zlotnik Shaul R (2012) Disciplining bioethics: towards a standard of methodological rigor in bioethics research. Account Res 19(3):187–207
Alvarez AAA (2001) How rational should bioethics be? The value of empirical approaches. Bioethics 15:501–519
Anonymous (2007) The method in bioethics research. Kennedy Inst Ethics J 17:277–278
Bahri P, Rägo L (2019) CIOMS guide to vaccine safety communication: executive summary. Vaccine 37:401–408
Baker DE (2009) Medication alert fatigue: the potential for compromised patient safety. Hosp Pharm 449(6):460–462
Bauchner H, Fontanarosa PB (2013) Restoring confidence in the pharmaceutical industry. JAMA 309:607–609
Beauchamp TL, Childress JF (2012) Principles of biomedical ethics, vol 51, 7th revised edn. Oxford University Press, Oxford
Bergstresser SM (2015) Health communication, public mistrust, and the politics of “rationality”. Am J Bioeth 15(4):57–59
Estrada C et al (1999) Health literacy and numeracy. JAMA 282(6):527
Fagerlin A, Ubel PA, Smith DM, Zikmund-Fisher BJ (2007) Making numbers matter: present and future research in risk communication. Am J Health Behav 31(Suppl 1):S47–S56
Floridi L (2010) Ethics after the information revolution. In: Floridi L (ed) The Cambridge handbook of information and computer ethics. Cambridge University Press, Cambridge, pp 3–19
Floridi L (2013) The ethics of information. Oxford University Press, Oxford
Folker AP, Sandøe P (2008) Leaping “out of the doubt” - nutrition advice: values at stake in communicating scientific uncertainty to the public. Health Care Anal 16:176–191
Galesic M, Garcia-Retamero R (2013) Using analogies to communicate information about health risks. Appl Cogn Psychol 27:33–42
Garcia-Retamero R, Andrade A, Sharit J, Ruiz JG (2015) Is patient’s numeracy related to physical and mental health? Med Decis Mak 35:501–511
Goodwin J, Honeycutt L (2009) When science goes public: from technical arguments to appeals to authority. Stud Commun Sci 9(2):19–30
Guttman N, Salmon CT (2004) Guilt, fear, stigma and knowledge gaps: ethical issues in public health communication interventions. Bioethics 18(6):531–552
Hall MA (2005) The importance of trust for ethics, law, and public policy. Camb Q Healthc Ethics 14:156–167
Hernandez JF, van Thiel GJMW, Mantel-Teeuwisse AK, Raaijmakers JAM, Pieters T (2014) Restoring trust in the pharmaceutical sector on the basis of the SSRI case. Drug Discov Today 19:523–527
Institute of Medicine (2010) Ethical issues in studying the safety of approved drugs: a letter report. The National Academies Press, Washington, pp 3–6
Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN (2009) Overrides of medication alerts in ambulatory care. Arch Intern Med 169(3):305–311
Ives J, Dunn M, Cribb A (2017) Theoretical perspectives: an introduction. In: Ives J, Dunn M, Cribb A (eds) Empirical bioethics. Theoretical and practical perspectives. Cambridge University Press, Cambridge, pp 3–16
Jones Ringold D (2002) Boomerang effects in response to public health interventions: some unintended consequences in the alcoholic beverage market. J Consum Policy 25:27–63
Kasperson RE (2015) Risk governance and the social amplification of risk: a commentary. In: Fra.Paleo U (ed) Risk governance. Springer, Dordrecht, pp 485–487
Kuczewski M (1998) Casuistry and principlism: the convergence of method in biomedical ethics. Theor Med Bioeth 19:509–524
Löfstedt R, Bouder F, Wardman J, Chakraborty S (2011) The changing nature of communication and regulation of risk in Europe. J Risk Res 14(4):409–429
Marantz PR (1990) Blaming the victim: the negative consequence of preventive medicine. Am J Public Health 80:1186–1187
McCormack L, Lefebvre RC, Bann C, Taylor O, Rausch P (2016) Consumer understanding, preferences, and responses to different versions of drug safety messages in the United States: a randomized controlled trial. Drug Saf 39:171–184
Minkler M (1999) Personal responsibility for health? A review of the arguments and the evidence at century’s end. Health Educ Behav 26(1):121–140
Molewijk AC, Siggelbout A, Otten W, Dupuis H, Kievit J (2004) Empirical data and moral theory. A plea for integrated empirical ethics. Med Health Care Philos 7:71–79
Nyhan B, Reifler J, Richey S, Freed GL (2014) Effective messages in vaccine promotion: a randomized trial. Pediatrics 133(4):e835–e842
Sidgwick H (1962) The methods of ethics. Macmillan, London, p 1
van Thiel, GJMW, Stolk PS (2013) Patient and citizen involvement in priority setting for pharmaceutical innovation. Background paper for the WHO Priority Medicines for Europe and the World 2013 report. WHO, Geneva
van Thiel GJMW, van Delden JJM (2010) Reflective equilibrium as a normative empirical model. Ethical Perspect 17:183–202
Vandekerckhove W (2018) Whistleblowing and information ethics: facilitation, entropy, and ecopoiesis. J Bus Ethics 152:15–25
Warburton P (2010) Numeracy and patient safety: the need for regular staff assessment. Nurs Stand 24(27):42–44
Widdershoven G, Abma T, Molewijk B (2009) Empirical ethics as dialogical practice. Bioethics 23:236–248
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
van Thiel, G. (2020). Ethical Frameworks. In: Bahri, P. (eds) Communicating about Risks and Safe Use of Medicines. Adis, Singapore. https://doi.org/10.1007/978-981-15-3013-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-3013-5_6
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-15-3012-8
Online ISBN: 978-981-15-3013-5
eBook Packages: MedicineMedicine (R0)